col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Future Medicine

466 Results       Page 1

  original article Journal Date Title Authors All Authors
1 [GO] Future Virology 2023―Sep―19 ‘The end’ - or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants Farid Rahimi, Mohammad Darvishi, Amin Talebi Bezmin Abadi
2 [GO] Nanomedicine 2023―Sep―15 Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine Bruna Rodrigues Dias Assis, Isabela Pereira Gomes, Júlia Teixeira de Castro, Graziella Gomes Rivelli, Natália Salazar de Castro, Diana Paola Gomez-Mendoza, et al. (+9)
3 [GO] Future Virology 2023―Sep―11 Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari
4 [GO] Future Microbiology 2023―Sep―05 Pandemic predictions and precautionary preparations: lessons from history Thomas H Pennington
5 [GO] Epigenomics 2023―Sep―04 Clinically informative microRNAs for SARS-CoV-2 infection Sercan Ergün, Ramamoorthy Sankaranarayanan, Nina Petrović
6 [GO] Biomarkers in Medicine 2023―Aug―31 Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19 Pavan K Bhatraju, Eric D Morrell, Nicholas G O'Connor, Audrey Choi, Michael Fitzpatrick, Craig H Smith, et al. (+2)
7 [GO] Regenerative Medicine 2023―Aug―17 Comment on ‘Digital transformation of medical education: innovative pedagogy and regenerative surgery in the era of COVID-19 Evelyn Casilla-Huamán
8 [GO] Regenerative Medicine 2023―Aug―09 Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19 Gaurav Gupta, Md Sadique Hussain, Riya Thapa, Rajiv Dahiya, Debarshi Kar Mahapatra, Asif Ahmad Bhat, et al. (+6)
9 [GO] Future Virology 2023―Jul―28 Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, et al. (+22)
10 [GO] Future Microbiology 2023―Jul―14 Antibiotic dispensing during first year of COVID-19 pandemic in Brazilian public hospitals Maria LS Pereira, Davi AC Mothé, Kézia S Pinheiro, Sarah S Gonçalves, Kênia V Santos
11 [GO] Future Virology 2023―Jul―13 Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, et al. (+3)
12 [GO] Immunotherapy 2023―Jul―11 An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S Fung, Pierre-Olivier Gaudreau
13 [GO] Future Virology 2023―Jun―24 Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation Cao Minh Nguyen, Bac An Luong, Thu Thuy Thi Tran, Hoai Nghia Nguyen, Le Son Tran
14 [GO] Future Virology 2023―Jun―23 Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, Keith Pietropaolo, Bruce Belanger, Kai Lin, et al. (+2)
15 [GO] Future Cardiology 2023―Jun―22 A young woman with pulmonary embolism, myocarditis and fungal endocarditis after COVID-19 infection: a case report Mehran Lak, Sepideh Jafari Naeini, Alireza Omidi Farzin, Manoochehr Hekmat, Atoosa Gharib
16 [GO] Biomarkers in Medicine 2023―Jun―20 Association between the copper/selenium ratio and the immune response to SARS-CoV-2 infection Mahnaz Tashakori, Ahmad Jamalizadeh, Mohsen Nejad-Ghaderi, Maryam Hadavi, Aliakbar Yousefi-Ahmadipour, Fatemeh M Moghadam, et al. (+4)
17 [GO] Future Virology 2023―Jun―16 COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities Abdul Mannan Baig, Joachim Gerlach, Prakash Salunke, Rachel Jessey, Robin Rose
18 [GO] Future Virology 2023―Jun―16 Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity Joachim Gerlach, Abdul Mannan Baig
19 [GO] Future Virology 2023―Jun―07 Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza, Hermógenes D de Oliveira
20 [GO] Future Virology 2023―Jun―01 CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, et al. (+4)
21 [GO] Future Virology 2023―Jun―01 Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari
22 [GO] Future Virology 2023―May―22 In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease Yousef A Abdelrady, Naeem Mahmood Ashraf, Arslan Hamid, Hayam S Thabet, Asmaa M Sayed, Shimaa H Salem, et al. (+2)
23 [GO] Future Virology 2023―May―22 Identification of host factors that bind to the 5′ end of the MERS-CoV RNA genome Bader Y Alhatlani, Waleed Aljabr, Fatimah S Alhamlan, Ahmad Almatroudi, Mohd Azam, Mansour Alsaleem, Khaled S Allemailem
24 [GO] Epigenomics 2023―May―02 COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape Mrinal K Ghosh, Sunny Kumar, Kirat K Ganguly, Pratyay Ghosh, Shaheda Tabassum, Bhaskar Basu, Malini Basu
25 [GO] Future Virology 2023―Apr―17 Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit Francesco Chirico, Murat Yıldırım, Tomasz Dzieciatkowski, Marek Dabrowski, Marek Malysz, Marcin Madziala, et al. (+5)
26 [GO] Future Virology 2023―Apr―11 DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu
27 [GO] Biomarkers in Medicine 2023―Apr―11 Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients Ömer Genç, Abdullah Yildirim, Mürşide Genç, Fahri Er, Gökhan Alici, Alaa Quisi, et al. (+3)
28 [GO] Future Virology 2023―Apr―11 In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Dyane Rocha Aragão, Expedito Maia Diógenes, Emerson Lucena da Silva, Jackson Lima Amaral, et al. (+3)
29 [GO] Future Virology 2023―Apr―06 The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex Mykyta Peka, Viktor Balatsky
30 [GO] Future Virology 2023―Apr―04 Evidence-based policies in public health to address COVID-19 vaccine hesitancy Francesco Chirico, Jaime A Teixeira da Silva
31 [GO] Personalized Medicine 2023―Mar―28 SARS-CoV-2 variant identification using a genome tiling array and genotyping probes Ryota Shimada, Emily N Alden, Kendall Hoff, Xun Ding, Jiayi Sun, Adam M Halasz, et al. (+2)
32 [GO] Future Microbiology 2023―Mar―14 Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study Gulsah Tuncer, Ceyda Geyiktepe-Guclu, Serkan Surme, Evren Canel-Karakus, Hatice Erdogan, Osman F Bayramlar, et al. (+17)
33 [GO] Future Virology 2023―Mar―14 Natural killer cells in COVID-19: from infection, to vaccination and therapy Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi
34 [GO] Future Virology 2023―Mar―09 A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed-Hamidreza Mozhgani
35 [GO] Future Virology 2023―Mar―06 Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike Massimo Ciccozzi, Stefano Pascarella
36 [GO] Future Virology 2023―Feb―20 HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, et al. (+3)
37 [GO] Concussion 2023―Feb―13 Return-to-learn after concussion in Washington state public high schools during the COVID-19 pandemic Shyam J Deshpande, Aspen Avery, Julian Takagi-Stewart, Brianna Mills, Qian Qiu, Monica S Vavilala
38 [GO] Future Virology 2023―Feb―03 SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening Jiahui Wu, Zhiqiang Chen, Xue Han, Qiaoqiao Chen, Yintao Wang, Tingting Feng
39 [GO] Future Virology 2023―Jan―27 Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern? Chandan Kumar Thakur, Jog Bahadur Adhikari, Nitin Gupta, Prakash Ghimire, Meghnath Dhimal
40 [GO] Future Virology 2023―Jan―19 Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19 Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge, Jun Ning
41 [GO] Future Microbiology 2023―Jan―17 Mucormycosis in the COVID-19 scenario beyond hospitalized patients Alexandro Bonifaz, Andrés Tirado-Sánchez, Javier Araiza, María Luisa Hernández-Medel
42 [GO] Future Virology 2023―Jan―16 Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, et al. (+20)
43 [GO] Immunotherapy 2023―Jan―11 Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients Mehrsa Jalalizadeh, Cristiane F Giacomelli, Patricia AF Leme, Keini Buosi, Luciana SB Dal Col, Franciele AV Dionato, et al. (+4)
44 [GO] Future Virology 2023―Jan―10 Diagnosing COVID-19: diagnostic importance of detecting E gene of the SARS-CoV-2 genome Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa
45 [GO] Future Virology 2023―Jan―09 The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Elahe Ghorbani Totkaboni, Haniyeh Sadat Fayazi
46 [GO] Pain Management 2022―Dec―14 Pain management recommendations during the progression of SARS-CoV-2 infection Arti Dhar, Preeti Kachroo, Maxime Herve, Richard Petruschke
47 [GO] Regenerative Medicine 2022―Dec―01 A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products Enric Redondo Monte, David O'Neill, Karin M Abitorabi
48 [GO] Future Virology 2022―Nov―25 Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, et al. (+26)
49 [GO] Future Oncology 2022―Nov―11 The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic Katia Roque, Rossana Ruiz, Iris Otoya-Fernandez, José Galarreta, Tatiana Vidaurre, Ramon Andrade de Mello, et al. (+3)
50 [GO] Future Cardiology 2022―Nov―02 2D speckle-tracking echocardiography as a prognostic imaging modality for COVID-19 adverse outcomes Ehsan Goudarzi, Fateme Yousefimoghaddam, Alireza Ramandi, Isa Khaheshi
51 [GO] Neurodegenerative Disease Management 2022―Oct―24 Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H Hua, Celia Oreja-Guevara, Daniel Selchen, et al. (+5)
52 [GO] Future Virology 2022―Oct―22 Variation analysis of SARS-CoV-2 complete sequences from Iran Jale Moradi, Parnia Moradi, Amir H Alvandi, Ramin Abiri, Mohsen Moghoofei
53 [GO] Future Oncology 2022―Oct―17 Remote consultations: experiences of UK patients with prostate cancer during the COVID-19 pandemic Rebecca Leszczynski, Natalia Norori, Steve Allen, Raj Persad, Toby Page, William Cross, et al. (+3)
54 [GO] Future Virology 2022―Oct―17 Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Melike Nur Ozcelik, Hulya Yilmaz-Ak, et al. (+4)
55 [GO] Future Microbiology 2022―Oct―06 Acinetobacter baumannii infections resistant to treatment: warning signs from the COVID-19 pandemic Ryan C Ellis, Elena K Roberts, Jennifer T Grier, Steven E Fiester
56 [GO] Future Oncology 2022―Sep―29 Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre Maria J Monroy-Iglesias, Kathryn Tremble, Beth Russell, Charlotte Moss, Saoirse Dolly, Ailsa Sita-Lumsden, et al. (+5)
57 [GO] Future Microbiology 2022―Sep―28 Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Filiz Pehlivanoglu, Gonul Sengoz
58 [GO] Future Virology 2022―Sep―26 Reinfection and reactivation of SARS-CoV-2 Razieh Dowran, Amirmasoud Rayati Damavandi, Talat Mokhtari Azad
59 [GO] Future Virology 2022―Sep―26 Rapid antigen test for SARS-CoV-2: results of validation and use in real life Irena Grmek Kosnik, Urska Dermota, Andrej Golle, Tjasa Zohar Cretnik
60 [GO] Journal of Comparative Effectiveness Research 2022―Sep―23 Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control design Matthew W Reynolds, Alex Secora, Alice Joules, Lisa Albert, Emma Brinkley, Tom Kwon, et al. (+3)
61 [GO] Future Virology 2022―Sep―23 Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations Ömer Kutlu, Selami Aykut Temiz
62 [GO] Future Virology 2022―Sep―16 Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support? Patrice Dufour, Henry Paridaens, Jean-Marc Senterre, Jean-Marc Minon
63 [GO] Future Microbiology 2022―Sep―16 Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21 Lucyana LC Coutinho, Caroline N Oliveira, Polianna LMM Albuquerque, Sandra MB Mota, Gdayllon C Meneses, Alice MC Martins, et al. (+6)
64 [GO] Future Microbiology 2022―Sep―16 Comment on: ‘Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients’ Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-García, Javier Mancilla-Galindo
65 [GO] Future Virology 2022―Sep―14 A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster Frank Struyf, Jerald Sadoff, Karin Hardt, Macaya Douoguih
66 [GO] Biomarkers in Medicine 2022―Sep―13 Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19 Serap Biberoğlu, Afşin İpekci, İbrahim İkizceli, Fatih Çakmak, Yonca S Akdeniz, Altuğ Kanbakan, et al. (+5)
67 [GO] Biomarkers in Medicine 2022―Sep―02 Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability Elba O Medina-Hernández, Lucía M Pérez-Navarro, Joselín Hernández-Ruiz, Alma Villalobos-Osnaya, María L Hernández-Medel, Catalina Casillas-Suárez, Adolfo Pérez-García
68 [GO] Biomarkers in Medicine 2022―Sep―02 Prognostic value of heparin-binding protein for mortality in severe COVID-19 pneumonia Tarık Acar, Birsen Ertekin, Mehmet Yortanlı, Sedat Koçak
69 [GO] Future Virology 2022―Aug―31 Sudden onset of decreased vision following Delta variant of SARS-CoV-2 infection: a case report Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian
70 [GO] Biomarkers in Medicine 2022―Aug―25 What is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey Safak O Balin, Ulku Kazanci, Kutbeddin Demirdag, Ayhan Akbulut
71 [GO] Future Virology 2022―Aug―08 Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey
72 [GO] Future Microbiology 2022―Aug―04 Follow-up study of anti-SARS-CoV-2 IgG antibody response in COVID-19 patients up to 6 months after infection Atalay Eray, Karamese Murat, Gumus Abdullah, Kahraman Ihsan, Kelesoglu Royca, Ozgur Didem, Tutuncu E Ediz
73 [GO] Future Virology 2022―Aug―02 Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy Alpo Vuorio, Petri T Kovanen, Frederick Raal
74 [GO] Future Virology 2022―Aug―02 Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations Kundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, Kam Y J Zhang, Tomokazu Ohishi, Nik Hirani, et al. (+4)
75 [GO] Personalized Medicine 2022―Aug―01 COVID-19 telehealth preparedness: a cross-sectional assessment of cardiology practices in the USA Carly E Waldman, Jean H Min, Heba Wassif, Andrew M Freeman, Anne K Rzeszut, Jack Reilly, et al. (+5)
76 [GO] Future Microbiology 2022―Jul―28 Role of the PD-1 and PD-L1 axis in COVID-19 Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry
77 [GO] Future Microbiology 2022―Jul―28 First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria Denis Niyazi, Borislava Toncheva, Tsvetan Tonchev, Deyan Dzhenkov, Kalin Kalchev, Temenuga Stoeva
78 [GO] Future Microbiology 2022―Jul―28 Coinfection with Strongyloides and Ascaris in a COVID-19-positive male presenting with acute abdomen: a case report Sweta Singh, Uday S Singh
79 [GO] Future Microbiology 2022―Jul―28 SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure Georgi Merhi, Jad Koweyes, Tamara Salloum, Charbel Al Khoury, Siwar Haidar, Sima Tokajian
80 [GO] Immunotherapy 2022―Jul―27 Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma Mikhail Razumikhin, Tatiana Smolyanova, Alevtina Nikolaeva, Ekaterina Orlova, Aleksandr Ivanov, Olga Belyakova, et al. (+9)
81 [GO] Future Microbiology 2022―Jul―26 G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19 Abir Mondal, Soumyadeep Mukherjee, Waseem Dar, Prince Upadhyay, Anand Ranganathan, Soumya Pati, Shailja Singh
82 [GO] Future Microbiology 2022―Jul―26 Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha Tjaša Ž Čretnik, Matjaž Retelj, Sandra Janežič, Aleksander Mahnič, Tine Tesovnik, Robert Šket, et al. (+9)
83 [GO] Future Virology 2022―Jul―22 Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2 Sara Ahmadi Badi, Shohreh Khatami, Seyed Davar Siadat
84 [GO] Immunotherapy 2022―Jul―20 Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19 Ragul Manoharan, Rajshekhar A Kore, Jawahar L Mehta
85 [GO] Future Virology 2022―Jul―19 A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19 Yusuf Emre Ozdemir, Adile Sevde Demir, Meryem Sahin Ozdemir, Busra Mavi, Can Ozen, Hayat Kumbasar Karaosmanoglu
86 [GO] Immunotherapy 2022―Jul―19 Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report Amalia Anastasopoulou, Aikaterini Gkoufa, Panagiotis Diamantopoulos, Spyridon Kazanas, Irene Eliadi, Michael Samarkos, Helen Gogas
87 [GO] Future Virology 2022―Jul―19 Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? Mingmei Zhao, Chunxiao Li, Yu Dong, Xuekun Wang, Wenqing Jiang, Yaogang Chen
88 [GO] Biomarkers in Medicine 2022―Jul―14 Is there a relationship between epicardial adipose tissue, inflammatory markers and prognosis in COVID-19 in patients under 65 years? Emre Emekli, Mustafa H Türkkanı, Sevgi S Ballı
89 [GO] Immunotherapy 2022―Jul―05 Effectiveness of COVID-19 vaccines against Omicron variant Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Claudio Bruno Silva de Oliveira, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira
90 [GO] Immunotherapy 2022―Jul―05 Reply to the letter ‘Effectiveness of COVID-19 vaccines against Omicron variant’ Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu, Vasso Apostolopoulos
91 [GO] Biomarkers in Medicine 2022―Jul―05 Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center MK Kalaivani, Shanthi Dinakar
92 [GO] Future Virology 2022―Jul―01 Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
93 [GO] Future Virology 2022―Jul―01 SARS-CoV-2 and its repercussive effect on reproductive health: recent trends Sukanth Kumar Enmozhi, Jerrine Joseph
94 [GO] Future Virology 2022―Jun―28 IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report Burak Göre, Ezgi Coşkun Yenigün, Şimal Köksal Cevher, Emre Çankaya, Numan Aydın, Fatih Dede
95 [GO] Future Cardiology 2022―Jun―23 Cardiac resynchronization therapy defibrillator: de novo implant in a COVID-19 patient by an echo-guided axillary venous approach Aldo Agea, Maria C Bellino, Domenico Gianfrancesco, Francesco Palma, Giuseppe A Carpagnano, Rita MR Torraco, et al. (+6)
96 [GO] Future Oncology 2022―Jun―20 Changing the landscape of European School of Oncology-European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic Nicholas Pavlidis, Fedro A Peccatori, Alexandru Eniu, Elie Rassy, Matti Aapro, Franco Cavalli, et al. (+2)
97 [GO] Future Virology 2022―Jun―16 A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, et al. (+4)
98 [GO] Future Virology 2022―Jun―15 Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience Hakan Apaydin, Abdulsamet Erden, Serdar C Güven, Berkan Armağan, Özlem Karakaş, Bahar Özdemir, et al. (+4)
99 [GO] Journal of Comparative Effectiveness Research 2022―Jun―14 Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA Kayla Engelbrecht, Srinjoy Roy, Gorana Capkun, Kristijan Kahler, Melvin Olson
100 [GO] Biomarkers in Medicine 2022―Jun―13 Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection Pamila Dua, Archana Mishra, KH Reeta
101 [GO] Immunotherapy 2022―Jun―13 Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report Angioletta Lasagna, Marco Vincenzo Lenti, Irene Cassaniti, Paolo Sacchi
102 [GO] Future Oncology 2022―Jun―09 Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination Urska Janzic, Urska Bidovec-Stojkovic, Katja Mohorcic, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanovic, et al. (+6)
103 [GO] Future Virology 2022―Jun―08 Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Cenk Serhan Ozverel, Emrah Guler, et al. (+3)
104 [GO] Future Cardiology 2022―Jun―06 Obese patients with long COVID-19 display abnormal hyperventilatory response and impaired gas exchange at peak exercise Mickael Rejaudry Lacavalerie, Sandrine Pierre-Francois, Moustapha Agossou, Jocelyn Inamo, André Cabie, José Luis Barnay, Rémi Neviere
105 [GO] Future Virology 2022―Jun―03 Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Samantha Vaishnavi, Apekshita Singh, Deepmala Sehgal, et al. (+3)
106 [GO] Future Virology 2022―Jun―03 Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, et al. (+5)
107 [GO] Biomarkers in Medicine 2022―May―16 Serum hemato-immunological biomarkers associated with increased COVID-19 mortality in the Latino population Carla PS Ríos, Oscar GJ Cabrera, Juan JJ-V Whaley, Marisol D Sosa, Victor HA Palacios, Guadalupe LH González, José CJ López
108 [GO] Biomarkers in Medicine 2022―May―09 Urinary tubular biomarkers as predictors of death in critically ill patients with COVID-19 Gabriela F Bezerra, Gdayllon C Meneses, Polianna LMM Albuquerque, Nicole C Lopes, Ranieri SS Santos, Juliana C da Silva, et al. (+12)
109 [GO] Future Virology 2022―May―09 Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens Forough Tavakoli, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat Mokhtari-Azad
110 [GO] Journal of Comparative Effectiveness Research 2022―May―06 Economic burden of drug overdose deaths before and during the coronavirus disease 2019 pandemic in the USA Briana Lui, Robert S White, Jaime Aaronson, Marguerite Hoyler
111 [GO] Journal of Comparative Effectiveness Research 2022―May―05 COVID-19 complications in males and females: recent developments Rahul Chaturvedi, Briana Lui, Jamie A Aaronson, Robert S White, Jon D Samuels
112 [GO] Future Microbiology 2022―May―05 Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19? Sheila Santa, Derek A Doku, Charles O Olwal, Charles A Brown, Emmanuel A Tagoe, Osbourne Quaye
113 [GO] Journal of Comparative Effectiveness Research 2022―May―05 Impact of coronavirus disease 2019 on chronic pain structures: data from French national survey Meggane Melchior, Mikhail Dziadzko, Séverine Conradi, Pierrick Poisbeau, Frédéric Aubrun
114 [GO] Future Microbiology 2022―May―05 Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective Abdo A Elfiky
115 [GO] Future Virology 2022―Apr―26 Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent Meng Zhang, Yixin Gong, Shunchang Jiao
116 [GO] Future Microbiology 2022―Apr―25 Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19 Malihe Naderi, Seyed Amir Soltani, Akram Taheri Rad, Zahra Mehrbakhsh, Sina Sodagar, Alireza Tahamtan, Seyedeh Sedigheh Hosseini
117 [GO] Future Microbiology 2022―Apr―20 Clostridioides difficile co-infection in patients with COVID-19 Roman Maslennikov, Vladimir Ivashkin, Anna Ufimtseva, Elena Poluektova, Anatoly Ulyanin
118 [GO] Future Virology 2022―Apr―19 Need for more robust research on the effectiveness of masks in preventing COVID-19 transmission Jingjing Nie, Linna Kang, Yaya Pian, Jihong Hu
119 [GO] Future Virology 2022―Apr―19 Toll-like receptor 4 in COVID-19: friend or foe? Suprabhat Mukherjee
120 [GO] Future Virology 2022―Apr―11 Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus Gannon CK Mak, Stephen SY Lau, Kitty KY Wong, Nancy LS Chow, Chi-Shan Lau, Edman TK Lam, et al. (+2)
121 [GO] Future Oncology 2022―Apr―06 Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic Hajer Hadi, Jasmine Handford, Beth Russell, Charlotte L Moss, Maria J Monroy Iglesias, Elke Rammant, et al. (+5)
122 [GO] Future Virology 2022―Apr―05 Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus Alberto Maria Cattaneo
123 [GO] Future Virology 2022―Apr―04 In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery Amira R Khattab, Mohamed Teleb
124 [GO] Future Microbiology 2022―Apr―01 Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children Danilo Buonsenso, Ferran Espuny Pujol, Daniel Munblit, Davide Pata, Sammie McFarland, Frances K Simpson
125 [GO] Biomarkers in Medicine 2022―Mar―30 Novel biomarker-based score (SAD-60) for predicting mortality in patients with COVID-19 pneumonia: a multicenter retrospective cohort of 1013 patients Serkan Surme, Gulsah Tuncer, Osman F Bayramlar, Betul Copur, Esra Zerdali, Inci Y Nakir, et al. (+8)
126 [GO] Biomarkers in Medicine 2022―Mar―30 Copeptin: a neuroendocrine biomarker of COVID-19 severity Reham Hammad, Ahmed Elshafei, Emad Gamil Khidr, Ahmed A El-Husseiny, Maher H Gomaa, Hend G Kotb, et al. (+2)
127 [GO] Future Microbiology 2022―Mar―30 Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2 Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, Sundararaj S Jeremiah, Michiharu Kudo, Akihide Ryo
128 [GO] Future Rare Diseases 2022―Mar―30 COVID-19 and the rare disease organization response during pandemic: the ‘Italian model’ Domenica Taruscio, Annalisa Scopinaro, Giuseppe Limongelli
129 [GO] Biomarkers in Medicine 2022―Mar―28 Homocysteine as a marker for predicting disease severity in patients with COVID-19 Adem Keskin, Goksenin U Ustun, Recai Aci, Utku Duran
130 [GO] Future Virology 2022―Mar―21 Can anti-parasitic drugs help control COVID-19? Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, et al. (+2)
131 [GO] Immunotherapy 2022―Mar―21 Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, Anselmo A Abdo Cuza, Yamilka Hernández Sánchez, Aylin Granado Rodríguez, et al. (+15)
132 [GO] Future Virology 2022―Mar―17 A community call to action: mitigating COVID pandemic’s impact on mental health Wahid Ullah, Muhammad Ilyas, Mukhtar Alam, Jong Bhak, Peter J Tonellato
133 [GO] Future Microbiology 2022―Mar―14 Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis Kevin Bouiller, Nathan Peiffer-Smadja, Muge Cevik, Katharina Last, Ivana A Antunović, Anja Šterbenc, et al. (+4)
134 [GO] Future Microbiology 2022―Mar―14 Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest Abdullah Al Saba, Maisha Adiba, Sajib Chakraborty, AHM Nurun Nabi
135 [GO] Journal of Comparative Effectiveness Research 2022―Mar―10 Economic burden of lives lost due to COVID-19 in California State Michelle Zheng, Briana Lui, Axell-Giovanni A Komlan, Christina R Bonaparte, Robert S White, Marguerite M Hoyler
136 [GO] Future Virology 2022―Mar―08 Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation Popy Devnath, Md. Jamal Hossain, Talha Bin Emran, Saikat Mitra
137 [GO] Biomarkers in Medicine 2022―Mar―02 Organ function biomarker abnormalities, associated factors and disease outcome among hospitalized patients with COVID-19 Shambel Araya, Yakob G Tsegay, Assegdew Atlaw, Mintsnot Aragaw, Getachew Tadlo, Nebiyu Tsegaye, et al. (+4)
138 [GO] Future Virology 2022―Mar―01 Airborne transmission of SARS-CoV-2 disease (COVID-19) Mohammad K Parvez, Shama Parveen
139 [GO] Future Microbiology 2022―Feb―24 Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki
140 [GO] Biomarkers in Medicine 2022―Feb―23 Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients Ákos Nádasdi, György Sinkovits, Ilona Bobek, Botond Lakatos, Zsolt Förhécz, Zita Z Prohászka, et al. (+9)
141 [GO] Immunotherapy 2022―Feb―21 A global picture: therapeutic perspectives for COVID-19 Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu, Vasso Apostolopoulos
142 [GO] Future Virology 2022―Feb―21 A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics Hanfei Zhang, Feiyang Zhong, Binchen Wang, Meiyan Liao
143 [GO] Biomarkers in Medicine 2022―Feb―18 Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT Roberto M Ferreira, Gabriel SS de Oliveira, João RF da Rocha, Felipe de MC Ribeiro, João J Stern, Rangel de S Costa, et al. (+6)
144 [GO] Future Microbiology 2022―Feb―15 Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic Daniele Focosi, Fabrizio Maggi, Scott McConnell, Arturo Casadevall
145 [GO] Future Virology 2022―Feb―11 Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report Alireza Ala, Solomon Habtemariam, Samad Shams Vahdati, Aysa Rezabakhsh
146 [GO] Future Virology 2022―Feb―10 Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19 Zhoujie Peng, Jing Zhang, Yuan Shi, Ming Yi
147 [GO] Future Virology 2022―Feb―10 Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19 Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, et al. (+2)
148 [GO] Future Virology 2022―Feb―10 Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis Serkan Guneyli, Hakan Dogan, Omer Tarik Esengur, Hur Hassoy
149 [GO] Future Microbiology 2022―Feb―09 Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody
150 [GO] Future Oncology 2022―Feb―07 Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic Taleb Khodaveisi, Farahnaz Sadoughi, Kambiz Novin, Mohammad Hosseiniravandi, Afsaneh Dehnad
151 [GO] Future Oncology 2022―Feb―03 SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate Alessandro Rizzo, Gennaro Palmiotti
152 [GO] Future Oncology 2022―Feb―02 An observational study of hospitalized COVID-19 patients with cancer in San Diego county David J Hermel, Jason Cham, Samantha R Spierling Bagsic, Lee K Hong, Carrie L Costantini, James R Mason, et al. (+2)
153 [GO] Future Virology 2022―Jan―31 Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, et al. (+7)
154 [GO] Biomarkers in Medicine 2022―Jan―27 Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients Mael Padelli, Papa Gueye, Diane Guilloux, Rishika Banydeen, Valentine Campana, Andre Cabie, Remi Neviere
155 [GO] Future Oncology 2022―Jan―27 Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study Ayse Irem Yasin, Sabin Göktas Aydin, Bilge Sümbül, Lokman Koral, Melih Şimşek, Çağlayan Geredeli, et al. (+23)
156 [GO] Future Microbiology 2022―Jan―19 Scrub typhus in two COVID-19 patients: a diagnostic dilemma Chandan Kumar Thakur, Priyam Batra, EV Vinayaraj, K Sreenath, Nisha Rathor, Urvashi B Singh, et al. (+5)
157 [GO] Future Microbiology 2022―Jan―19 Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank Michael Frank
158 [GO] Journal of Comparative Effectiveness Research 2022―Jan―18 Impact of telehealth on health care resource utilization during the COVID-19 pandemic Prachi Arora, Darshan Mehta, Jane Ha
159 [GO] Future Oncology 2022―Jan―17 The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer Kathryn Tremble, Louis Fox, Charlotte Moss, Beth Russell, Haleema Aljazzaf, Finola Higgins, et al. (+6)
160 [GO] Journal of Comparative Effectiveness Research 2022―Jan―13 Respiratory and nonrespiratory COVID-19 complications in patients with obesity: recent developments Esther Liu, Hudson Lee, Briana Lui, Robert S White, Jon D Samuels
161 [GO] Epigenomics 2022―Jan―13 The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks Milad Shirvaliloo
162 [GO] Future Virology 2022―Jan―12 Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses Jean-François Rossignol
163 [GO] Future Virology 2022―Jan―12 Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour
164 [GO] Future Oncology 2022―Jan―12 Pattern of breast cancer presentation during the coronavirus disease pandemic: results from a cohort study in the UK Kim Borsky, Ketan Shah, Giles Cunnick, Fiona Tsang-Wright
165 [GO] Nanomedicine 2022―Jan―11 Role of nanomedicine in COVID-19 therapeutics Smriti Sharma
166 [GO] Journal of Comparative Effectiveness Research 2022―Jan―11 Variant analysis of SARS-CoV-2 strains with phylogenetic analysis and the Coronavirus Antiviral and Resistance Database Murat Sayan, Ayse Arikan, Murat Isbilen
167 [GO] Future Microbiology 2021―Dec―17 Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 Iftikhar Nadeem, Louise Jordon, Masood Ur Rasool, Noor Mahdi, Ritesh Kumar, Zahra Rehman, et al. (+5)
168 [GO] Future Microbiology 2021―Dec―17 Inflammation at the crossroads of Helicobacter pylori and COVID-19 Ileana Gonzalez, Cristian Lindner, Ivan Schneider, Miguel A Morales, Armando Rojas
169 [GO] Future Virology 2021―Dec―15 A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt
170 [GO] Future Virology 2021―Dec―15 Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak
171 [GO] Future Virology 2021―Dec―15 Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn
172 [GO] Future Virology 2021―Dec―06 Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey
173 [GO] Future Virology 2021―Dec―03 Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, et al. (+5)
174 [GO] Neurodegenerative Disease Management 2021―Dec―02 COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report Gooya Tayyebi, Seyed Kazem Malakouti, Behnam Shariati, Leila Kamalzadeh
175 [GO] Future Oncology 2021―Dec―01 Impact of corona-phobia on attitudes and acceptance towards COVID-19 vaccine among cancer patients: a single-center study Dilek Erdem, Irem Karaman
176 [GO] Future Virology 2021―Nov―26 A brief review on DNA vaccines in the era of COVID-19 Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, et al. (+9)
177 [GO] Future Virology 2021―Nov―26 Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh
178 [GO] Future Oncology 2021―Nov―26 Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2 Oktay Ünsal, Ozan Yazıcı, Nuriye Özdemir, Erdem Çubukçu, Birol Ocak, Aytuğ Üner, Ahmet Özet
179 [GO] Future Virology 2021―Nov―26 Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi
180 [GO] Future Microbiology 2021―Nov―23 Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients Serkan Surme, Gulsah Tuncer, Betul Copur, Esra Zerdali, Inci Yilmaz Nakir, Meltem Yazla, et al. (+7)
181 [GO] Pain Management 2021―Nov―23 Acute worsening of clinical presentation in CRPS after SARS-CoV-2 (COVID-19) vaccination: a case series Jessica Zhang, Semih Gungor
182 [GO] Future Microbiology 2021―Nov―23 Drug-based therapeutic strategies for COVID-19-infected patients and their challenges Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, et al. (+5)
183 [GO] Immunotherapy 2021―Nov―22 Nimotuzumab for COVID-19: case series Anselmo A Abdo Cuza, Jonathan Pi Ávila, Rafael Machado Martínez, José Jordán González, Guillermo Pérez Aspuro, Juan A Gutiérrez Martínez, et al. (+4)
184 [GO] Biomarkers in Medicine 2021―Nov―17 Prognostic Nutritional Index and CRP, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-19 Mehmet Bayram, Ozgur Yildirim, Raye S Ozmen, Beyza Soylu, Ahmet S Dundar, Ali R Koksal, et al. (+3)
185 [GO] Biomarkers in Medicine 2021―Nov―17 Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field Marília B Visacri, Aline de S Nicoletti, Eder de C Pincinato, Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al. (+2)
186 [GO] Future Virology 2021―Nov―12 Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, et al. (+2)
187 [GO] Future Virology 2021―Nov―12 Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy Sayantan Laha, Raghunath Chatterjee
188 [GO] Future Microbiology 2021―Nov―11 Current status of therapeutic approaches and vaccines for SARS-CoV-2 Braira Wahid, Anam Amir, Ayesha Ameen, Muhammad Idrees
189 [GO] Future Microbiology 2021―Nov―10 Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV Sarah Aherfi, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, Didier Raoult
190 [GO] Immunotherapy 2021―Nov―08 The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't Alexandre E Malek, Paulette Pinargote Cornejo, Nour Daoud, Mohammad Alam
191 [GO] Future Virology 2021―Nov―04 The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi
192 [GO] Future Virology 2021―Nov―04 In-hospital clinical complications of COVID-19: a brief overview Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal
193 [GO] Future Virology 2021―Nov―04 The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants Farid Rahimi, Amin Talebi Bezmin Abadi
194 [GO] Future Virology 2021―Nov―04 SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system Tariq Khan, Syed Muhammad Jamal
195 [GO] Nanomedicine 2021―Nov―03 Mucoadhesive nanoformulations and their potential for combating COVID-19 Parteek Prasher, Mousmee Sharma
196 [GO] Future Oncology 2021―Nov―02 Factors associated with fatal coronavirus disease 2019 infections among cancer patients in the US FDA Adverse Event Reporting System database Omar Abdel-Rahman
197 [GO] Future Virology 2021―Oct―29 The international treaty for pandemic preparedness and response: same story, different times? Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane
198 [GO] Future Microbiology 2021―Oct―25 Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection Muhammad Asif, Mohammad Saleem, Hafiza Sidra Yaseen, Ashwaq HS Yehya, Malik Saadullah, Hafiz Muhammad Zubair, et al. (+4)
199 [GO] Future Microbiology 2021―Oct―22 A comparative study of the mental health impact of the COVID-19 pandemic on health care professionals in India Jitender Jakhar, Partha Sarathi Biswas, Mahima Kapoor, Amandeep Panghal, Amit Meena, Harsha Fani, Pradip Kharya
200 [GO] Future Oncology 2021―Oct―21 Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice Georges Abi Tayeh, Nour Khalil, Marwan Alkassis, Fouad Aoun, Chady Waked, Elie Nemr
201 [GO] Biomarkers in Medicine 2021―Oct―20 Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19 Selda Murat, Bektas Murat, Muhammet Dural, Gurbet Ozge Mert, Yuksel Cavusoglu
202 [GO] Biomarkers in Medicine 2021―Oct―20 Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure Sana Asif, Thoralph Ruge, Anders Larsson, Sara Bülow Anderberg, Miklos Lipcsey, Robert Fritiof, Michael Hultström
203 [GO] Future Virology 2021―Oct―19 Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi
204 [GO] Personalized Medicine 2021―Oct―15 Personalized therapy: can it tame the COVID-19 monster? Mohd Arish, Farha Naz
205 [GO] Future Virology 2021―Oct―14 Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni
206 [GO] Nanomedicine 2021―Oct―11 Nano-carriers of COVID-19 vaccines: main pillars of efficacy Carolina Constantin, Anissa Pisani, Giuseppe Bardi, Monica Neagu
207 [GO] Personalized Medicine 2021―Oct―08 Intelligent health system for investigation and consenting COVID-19 patients and precision medicine Zeeshan Ahmed
208 [GO] Future Virology 2021―Oct―08 Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? Lei Huang
209 [GO] Future Virology 2021―Oct―08 A case series of pediatric COVID-19 with complicated symptoms in Iran Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, et al. (+3)
210 [GO] Future Microbiology 2021―Oct―07 Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey Murat Karamese, Didem Ozgur, Emin E Tutuncu
211 [GO] Pain Management 2021―Oct―04 Myofascial pain syndrome and SARS-CoV-2: a case series Jaldhi Patel, Saba Javed
212 [GO] Immunotherapy 2021―Sep―29 Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research Angioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli
213 [GO] Future Virology 2021―Sep―22 Association between blood groups and COVID-19 outcome in Iranian patients Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, et al. (+2)
214 [GO] Future Virology 2021―Sep―21 High-value laboratory testing for hospitalized COVID-19 patients: a review Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, et al. (+8)
215 [GO] Biomarkers in Medicine 2021―Sep―20 Prospective selected biomarkers in COVID-19 diagnosis and treatment Tahani Tabassum, Ahsab Rahman, Yusha Araf, Md A Ullah, Mohammad J Hosen
216 [GO] Future Virology 2021―Sep―10 Fast evolution of SARS-CoV-2 driven by deamination systems in hosts Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, et al. (+2)
217 [GO] Future Oncology 2021―Sep―03 Predictors of poor precautionary practices towards COVID-19 among cancer patients Abdul R Jazieh, Assia A Bensalem, Adda Bounedjar, Zineb Benbrahim, Mohamed O Alorabi, Atlal M Abusanad, et al. (+9)
218 [GO] Future Cardiology 2021―Sep―03 COVID-19, cardiovascular diseases and cardiac troponins Chan W Kim, Wilbert S Aronow
219 [GO] Future Virology 2021―Sep―02 Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh
220 [GO] Biomarkers in Medicine 2021―Sep―02 Emerging treatments for COVID-19: déjà vu all over again? Ricardo AC Lima, Roberto M Ferreira
221 [GO] Future Virology 2021―Sep―02 mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut
222 [GO] Future Microbiology 2021―Sep―01 Coronaviruses construct an interconnection way with ERAD and autophagy Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour
223 [GO] Future Microbiology 2021―Sep―01 SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, et al. (+8)
224 [GO] Journal of Comparative Effectiveness Research 2021―Aug―31 Comparative effectiveness research in COVID-19 using real-world data: methodological considerations Stephanie H Read, Artak Khachatryan, Aastha Chandak, Roman Casciano, Paul Hodgkins, Richard Haubrich, Essy Mozaffari
225 [GO] Immunotherapy 2021―Aug―25 Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis Wenwei Qian, Ying Ye, Lugen Zuo, Ting Song, Qing Xu, Yinghong Wang, et al. (+2)
226 [GO] Future Oncology 2021―Aug―25 Thyroid cancer surgery during the coronavirus disease 2019 pandemic: perioperative management and oncological and anatomical considerations Eleftherios Spartalis, Nikolaos Plakopitis, Maria Anna Theodori, Sotirios P Karagiannis, Dimitrios I Athanasiadis, Michael Spartalis, et al. (+4)
227 [GO] Nanomedicine 2021―Aug―25 Carbon nanomaterials as promising substrates in the design of sensors for SARS-CoV-2 and new emerging viral infections Sepideh Abbaszadeh, Ghazal Nikaeen, Saeed Yousefinejad
228 [GO] Biomarkers in Medicine 2021―Aug―18 Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS coronavirus-2 Saban Kelesoglu, Yucel Yilmaz, Eyup Ozkan, Bekir Calapkorur, Zehra B Dursun, Aysegul Ulu-Kilic, Deniz Elcık
229 [GO] Future Virology 2021―Aug―09 Harnessing immunological targets for COVID-19 immunotherapy Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
230 [GO] Journal of 3D Printing in Medicine 2021―Aug―09 Industrial applications of 3D printing to scale-up production of COVID-19-related medical equipment Muhammad Zaheer Abbas
231 [GO] Future Virology 2021―Jul―29 Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients Gerald Chi, Sahar Memar Montazerin, Jane J Lee
232 [GO] Future Microbiology 2021―Jul―28 Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok
233 [GO] Future Microbiology 2021―Jul―28 Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi
234 [GO] Future Oncology 2021―Jul―22 Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic Ayse Irem Yasin, Atakan Topcu, Abdallah TM Shbair, Zehra Sucuoglu Isleyen, Ahmet Ozturk, Mehmet Besiroglu, Hacı Mehmet Türk
235 [GO] Biomarkers in Medicine 2021―Jul―21 National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19 Gulsah Tuncer, Serkan Surme, Osman F Bayramlar, Hatice K Karanalbant, Betul Copur, Meltem Yazla, et al. (+10)
236 [GO] Neurodegenerative Disease Management 2021―Jul―21 A survey on patients' disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia Suzanna Edgar, Nur Adilah Abdul-Aziz, Ee Chin Loh, David Capelle, Khean-Jin Goh, Lydia Abdul Latif, et al. (+2)
237 [GO] Future Virology 2021―Jul―20 Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation Claudia Cava, Gloria Bertoli, Isabella Castiglioni
238 [GO] Future Virology 2021―Jul―20 An overview of sex hormones in relation to SARS-CoV-2 infection Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani
239 [GO] Future Virology 2021―Jul―20 In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database Eldar Muhtar, Mengyang Wang, Haimei Zhu
240 [GO] Future Oncology 2021―Jul―19 Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub Stefano Luzzago, Francesco A Mistretta, Enza Dossena, Gianna Comandi, Giovanni Petralia, Dario Di Trapani, et al. (+6)
241 [GO] Future Oncology 2021―Jul―15 Cancer and COVID-19: analysis of patient outcomes Mohamed Aboueshia, Mohammad Hosny Hussein, Abdallah S Attia, Aubrey Swinford, Peter Miller, Mahmoud Omar, et al. (+5)
242 [GO] Journal of 3D Printing in Medicine 2021―Jul―13 Use of 3D printing to support COVID-19 medical supply shortages: a review Stephanie Ishack, Shari R Lipner
243 [GO] Future Virology 2021―Jul―13 Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study Ajita Pandey, Mohit Sharma
244 [GO] Future Oncology 2021―Jul―13 Is obesity a risk factor in cancer patients with COVID-19? Robin Park, Elizabeth Wulff-Burchfield, Weijing Sun, Anup Kasi
245 [GO] Future Virology 2021―Jul―13 Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh
246 [GO] Future Virology 2021―Jul―08 Association of anemia and COVID-19 in hospitalized patients Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng
247 [GO] Epigenomics 2021―Jul―06 Implication of epitranscriptomics in trained innate immunity and COVID-19 Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan
248 [GO] Future Virology 2021―Jul―06 Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu
249 [GO] Future Microbiology 2021―Jul―05 Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, et al. (+7)
250 [GO] Future Oncology 2021―Jun―30 Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination Bangyu Luo, Jixi Li, Xianhua Hou, Qiao Yang, Yi Zhou, Jun Ye, et al. (+6)
251 [GO] Future Virology 2021―Jun―30 Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan
252 [GO] Future Microbiology 2021―Jun―24 Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni
253 [GO] Future Virology 2021―Jun―22 The COVID-19 pandemic: an increased risk of rheumatoid arthritis Archana Tripathy, Nitish Swain, Bhawna Gupta
254 [GO] Future Virology 2021―Jun―22 V483A: an emerging mutation hotspot of SARS-CoV-2 Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque
255 [GO] Future Virology 2021―Jun―22 Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing
256 [GO] Pharmacogenomics 2021―Jun―18 Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes S Sahana, Ambily Sivadas, Mohit Mangla, Abhinav Jain, Rahul C Bhoyar, Kavita Pandhare, et al. (+47)
257 [GO] Regenerative Medicine 2021―Jun―11 Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19 Mina Kim, Paul S Knoepfler
258 [GO] Immunotherapy 2021―Jun―11 Appropriate use of antimicrobial therapy for COVID-19 co-infection Chih-Cheng Lai, Wen-Liang Yu
259 [GO] Future Oncology 2021―Jun―09 Telehealth amid the COVID19 pandemic: perception among Asian, Native Hawaiian and Pacific Islander cancer patients Michael Meno, Justin Abe, Jami Fukui, Christa Braun-Inglis, Ian Pagano, Jared Acoba
260 [GO] Future Microbiology 2021―Jun―04 Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau Joseph Blondeau
261 [GO] Personalized Medicine 2021―Jun―04 Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection Manik Vohra, Anu Radha Sharma, Kapaettu Satyamoorthy, Padmalatha S Rai
262 [GO] Journal of Comparative Effectiveness Research 2021―Jun―01 Economic burden of lives lost due to COVID-19 in New York State Briana Lui, Michelle Zheng, Robert S White, Marguerite Hoyler
263 [GO] Future Virology 2021―Jun―01 Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar
264 [GO] Nanomedicine 2021―May―28 Special Focus Issue - Applications of nanotechnology against COVID-19: a special focus issue by Nanomedicine Alice Bough
265 [GO] Future Virology 2021―May―24 Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong
266 [GO] Future Virology 2021―May―19 Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang
267 [GO] Future Virology 2021―May―19 SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses Andrew P Rice, Jason T Kimata
268 [GO] Future Microbiology 2021―May―17 Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez Peter Hotez
269 [GO] Nanomedicine 2021―May―17 Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation Priya Singh, Deepika Singh, Pratikshya Sa, Priyanka Mohapatra, Auromira Khuntia, Sanjeeb K Sahoo
270 [GO] Biomarkers in Medicine 2021―May―14 COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings Salvatore Fuschillo, Pasquale Ambrosino, Andrea Motta, Mauro Maniscalco
271 [GO] Regenerative Medicine 2021―May―14 Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy? Gaia Spinetti, Elisa Avolio, Paolo Madeddu
272 [GO] Biomarkers in Medicine 2021―May―14 Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience Eman Farid, Kannan Sridharan, Ola AM Alsegai, Safa Al Khawaja, Eman J Mansoor, Noor A Teraifi, et al. (+2)
273 [GO] Nanomedicine 2021―May―14 Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics Alaa F Nahhas, Alrayan F Nahhas, Thomas J Webster
274 [GO] Nanomedicine 2021―May―13 Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro Richa Vartak, Suyash M Patil, Aishwarya Saraswat, Manali Patki, Nitesh K Kunda, Ketan Patel
275 [GO] Future Virology 2021―May―12 Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, et al. (+8)
276 [GO] Journal of 3D Printing in Medicine 2021―May―11 3D printing in surgical simulation: emphasized importance in the COVID-19 pandemic era Ross Michaels, Chelsey A Witsberger, Allison R Powell, Krishna Koka, Katheryn Cohen, Zahra Nourmohammadi, et al. (+2)
277 [GO] Nanomedicine 2021―May―11 How has nanomedical innovation contributed to the COVID-19 vaccine development? João Paulo Figueiró Longo, Luis Alexandre Muehlmann
278 [GO] Future Microbiology 2021―May―11 Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response Xin Chen, Mingli Gu, Tengda Li, Yi Sun
279 [GO] Nanomedicine 2021―May―11 Nanotechnology-based self-sterilizing surfaces and their potential in combating coronavirus disease 2019 Parteek Prasher, Mousmee Sharma
280 [GO] Future Microbiology 2021―May―07 Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris
281 [GO] Journal of 3D Printing in Medicine 2021―May―05 The role of 3D printing in the fight against COVID-19 outbreak Payar Radfar, Sajad Razavi Bazaz, Fateme Mirakhorli, Majid Ebrahimi Warkiani
282 [GO] Immunotherapy 2021―Apr―28 Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante
283 [GO] Future Virology 2021―Apr―26 An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh
284 [GO] Journal of Comparative Effectiveness Research 2021―Apr―23 Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia Mehmet Agirbasli, Azra Tanrıkulu
285 [GO] Future Virology 2021―Apr―22 HIV and COVID-19 pandemic collision: turning challenges into opportunity Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli
286 [GO] Future Virology 2021―Apr―21 Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram
287 [GO] Future Cardiology 2021―Apr―20 Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor Daanyaal Wasim, Bjørn Alme, Stina Jordal, Tomas Mikal Lind Eagan, Marijana Tadic, Giuseppe Mancia, et al. (+2)
288 [GO] Epigenomics 2021―Apr―20 Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection Milad Shirvaliloo
289 [GO] Future Virology 2021―Apr―14 The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period Hamid Tayebi Khosroshahi, Alireza Mardomi
290 [GO] Future Microbiology 2021―Apr―13 Herd immunity: could it bring the COVID-19 pandemic to an end? Thomas Hugh Pennington
291 [GO] Future Microbiology 2021―Apr―13 The interplay of SARS-CoV-2 and Clostridioides difficile infection Sahil Khanna, Colleen S Kraft
292 [GO] Future Virology 2021―Apr―07 Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, et al. (+5)
293 [GO] Future Virology 2021―Apr―06 Xerostomia (dry mouth) in patients with COVID-19: a case series Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi
294 [GO] Biomarkers in Medicine 2021―Mar―29 Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19 Zhikun Zeng, Xiao-Yue Hong, Yunhui Li, Wei Chen, Guangming Ye, Yirong Li, Yi Luo
295 [GO] Future Virology 2021―Mar―25 Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee
296 [GO] Journal of 3D Printing in Medicine 2021―Mar―24 COVID-19 and the worldwide actions to mitigate its effects using 3D printing Guilherme Arthur Longhitano, Jorge Vicente Lopes da Silva
297 [GO] Future Virology 2021―Mar―24 The role of miRNAs in COVID-19 disease Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi
298 [GO] Pharmacogenomics 2021―Mar―24 Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients Mohitosh Biswas
299 [GO] Future Cardiology 2021―Mar―19 SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges Kevin S Shah, Mary Elizabeth Hale Hammond, Stavros G Drakos, Jeffrey L Anderson, James C Fang, Kirk U Knowlton, Robin M Shaw
300 [GO] Future Microbiology 2021―Mar―12 COVID-19 pneumonia: do not leave the corticosteroids behind! Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa
301 [GO] Video Journal of Biomedicine 2021―Mar―11 Managing colorectal cancer patients in the COVID-19 era: international discussion on the role of precision medicine in triaging patients
302 [GO] Epigenomics 2021―Mar―09 An immune epigenetic insight to COVID-19 infection Bimal P Jit, Sahar Qazi, Rakesh Arya, Ankit Srivastava, Nimesh Gupta, Ashok Sharma
303 [GO] Future Virology 2021―Mar―09 Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi
304 [GO] Nanomedicine 2021―Mar―08 Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives Hamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, Faezeh Mozafari, Marziyeh Salehiabar, Mohammad Amin Rahmati, et al. (+13)
305 [GO] Future Virology 2021―Mar―08 Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari
306 [GO] Biomarkers in Medicine 2021―Mar―05 Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era George A Alexiou, Georgios D Lianos, Eleftherios-Spyridon Alexiou, Spyridon Voulgaris
307 [GO] Future Virology 2021―Mar―02 Computational guided approach for drug repurposing against SARS-CoV-2 Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai
308 [GO] Future Oncology 2021―Feb―26 Patient satisfaction with telemedicine for prechemotherapy evaluation during the COVID-19 pandemic Ajithraj Sathiyaraj, Hannah Lopez, Rakesh Surapaneni
309 [GO] Future Virology 2021―Feb―24 Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, et al. (+3)
310 [GO] Future Virology 2021―Feb―22 Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti
311 [GO] Journal of Comparative Effectiveness Research 2021―Feb―17 Estimates of the value of life lost from COVID-19 in Ohio Peter J Mallow
312 [GO] Future Cardiology 2021―Feb―12 Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors Milad Shirvaliloo
313 [GO] Future Microbiology 2021―Feb―11 Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
314 [GO] Immunotherapy 2021―Feb―09 Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma Shaukat Ali, Syed M Uddin, Ayesha Ali, Fatima Anjum, Rashid Ali, Elisha Shalim, et al. (+7)
315 [GO] Future Virology 2021―Feb―09 The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, et al. (+2)
316 [GO] Future Oncology 2021―Feb―04 The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients Melissa Bersanelli, Diana Giannarelli, Alessandro Leonetti, Sebastiano Buti, Marcello Tiseo, Antonio Nouvenne, et al. (+4)
317 [GO] Future Virology 2021―Feb―04 What is the intermediate host species of SARS-CoV-2? Thomas Friend, Justin Stebbing
318 [GO] Future Oncology 2021―Feb―03 Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Martina Merli, et al. (+3)
319 [GO] Future Virology 2021―Feb―03 SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag
320 [GO] Journal of 3D Printing in Medicine 2021―Feb―02 3D-printed valves to assist noninvasive ventilation procedures during the COVID-19 pandemic: a case study Guilherme Arthur Longhitano, Geovany Candido, Leonardo Mendes Ribeiro Machado, Paulo Inforçatti Neto, Marcelo Fernandes de Oliveira, Pedro Yoshito Noritomi, et al. (+3)
321 [GO] Future Virology 2021―Jan―28 Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, et al. (+8)
322 [GO] Biomarkers in Medicine 2021―Jan―27 Evaluation of the relation between cardiac biomarkers and thorax computerized tomography findings in COVID-19 patients Cigdem Ileri, Zekeriya Dogan, Beste Ozben, Cagla Karaoglu, Nuran Gunay, Kursat Tigen, et al. (+2)
323 [GO] Future Virology 2021―Jan―26 Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, et al. (+6)
324 [GO] Future Virology 2021―Jan―25 Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, et al. (+3)
325 [GO] Future Microbiology 2021―Jan―25 COVID-19: it is all about sepsis Jean-Louis Vincent
326 [GO] Future Microbiology 2021―Jan―19 Review of the use of nasal and oral antiseptics during a global pandemic Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar
327 [GO] Future Microbiology 2021―Jan―18 The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 Mayra Cuéllar-Cruz
328 [GO] Future Virology 2021―Jan―13 Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini
329 [GO] Future Virology 2021―Jan―07 A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols Michael L Hitchman
330 [GO] Future Microbiology 2021―Jan―06 Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, et al. (+2)
331 [GO] Future Microbiology 2021―Jan―06 Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye
332 [GO] Immunotherapy 2021―Jan―05 An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, et al. (+11)
333 [GO] Future Virology 2020―Dec―24 Relationship between IL-6 and COVID-19: to be considered during treatment Hafize Seda Vatansever, Eda Becer
334 [GO] Future Microbiology 2020―Dec―22 COVID-19: mask efficacy is dependent on both fabric and fit Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, et al. (+3)
335 [GO] Future Cardiology 2020―Dec―17 A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia Luigi Cappannoli, Alessandro Telesca, Roberto Scacciavillani, Edoardo Petrolati, Andrea Smargiassi, Alessia Rabini, et al. (+3)
336 [GO] Future Oncology 2020―Dec―17 TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the coronavirus disease 2019 pandemic Ziyao Wang, YaNan Kang, FuRong Yu, Feng-Hui Zhong, Kangni Huang, Xuan Zhou, et al. (+4)
337 [GO] Future Virology 2020―Dec―16 Pandemic response management framework based on efficiency of COVID-19 control and treatment Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi
338 [GO] Future Virology 2020―Dec―15 Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? Yashwant Kumar, Reena Yadav, Alka Bhatia
339 [GO] Immunotherapy 2020―Dec―14 Immunity to glycan α-Gal and possibilities for the control of COVID-19 José de la Fuente, Christian Gortázar, Alejandro Cabezas-Cruz
340 [GO] Journal of 3D Printing in Medicine 2020―Dec―07 COVID-19: additive manufacturing response in the UK Elen J Parry, Craig E Banks
341 [GO] Nanomedicine 2020―Dec―03 New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment Virna Margarita Martín Giménez, Natalia Prado, Emiliano Diez, Walter Manucha, Russel J Reiter
342 [GO] Future Oncology 2020―Dec―02 ‘Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?’ Retraction notice
343 [GO] Future Oncology 2020―Dec―02 Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience Christine Salem, Marie-Ange Hajj, Hampig Kourié, Antoine Haddad, Abir Khaddage, Eliane Nasser Ayoub, et al. (+3)
344 [GO] Journal of 3D Printing in Medicine 2020―Dec―01 Pivoting: from academic 3D printing to rapid COVID-19 solutions Allison R Powell, Charles A Keilin, Ross E Michaels, Owen J Tien, Kyle K VanKoevering, Glenn E Green, David A Zopf
345 [GO] Journal of 3D Printing in Medicine 2020―Dec―01 Potential risks of a widespread use of 3D printing for the manufacturing of face masks during the severe acute respiratory syndrome coronavirus 2 pandemic Sven Duda, Sascha Hartig, Karola Hagner, Lisa Meyer, Paula Wessling Intriago, Tobias Meyer, Heinrich Wessling
346 [GO] Future Virology 2020―Nov―30 Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig
347 [GO] Future Oncology 2020―Nov―27 COVID-19 and breast cancer: may the microbiome be the issue? Angioletta Lasagna, Valentina Zuccaro, Elisa Ferraris, Marta Corbella, Raffaele Bruno, Paolo Pedrazzoli
348 [GO] Future Oncology 2020―Nov―27 In reply to the Letter to the Editor on: telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
349 [GO] Pharmacogenomics 2020―Nov―27 Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry Georgia Ragia, Vangelis G Manolopoulos
350 [GO] Journal of Comparative Effectiveness Research 2020―Nov―27 Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019 Mohamed Rafiullah, Khalid Siddiqui
351 [GO] Future Virology 2020―Nov―26 The role of artificial intelligence in tackling COVID-19 Neelima Arora, Amit K Banerjee, Mangamoori L Narasu
352 [GO] Epigenomics 2020―Nov―26 An integrative analysis identifying transcriptional features and key genes involved in COVID-19 Guoping Li, Junyi Wang, Xiang He, Lei Zhang, Qin Ran, Anying Xiong, et al. (+4)
353 [GO] Future Virology 2020―Nov―26 Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh Nadim Sharif, Shuvra K Dey
354 [GO] Future Microbiology 2020―Nov―24 Chloroquine/hydroxycloroquine and COVID-19: need to know more about Antonio Cassone, Licia Iacoviello, Roberto Cauda
355 [GO] Future Microbiology 2020―Nov―20 The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic Lígia N de M Ribeiro, Belchiolina B Fonseca
356 [GO] Future Microbiology 2020―Nov―12 Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, et al. (+7)
357 [GO] Neurodegenerative Disease Management 2020―Nov―11 Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use? Andrew J Larner
358 [GO] Future Microbiology 2020―Nov―06 Clinical microbiology laboratories and COVID-19: the calm before the storm Joseph M Blondeau
359 [GO] Future Microbiology 2020―Nov―06 Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation Michael B Yakass, Osbourne Quaye, Bryan J Woodward
360 [GO] Future Virology 2020―Nov―04 LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? Su M Metcalfe
361 [GO] Future Microbiology 2020―Nov―03 Coronavirus pandemic: treatment and future prevention Kenneth Lundstrom
362 [GO] Future Cardiology 2020―Oct―30 Cardiology and COVID-19: do we have sufficient information? Nikita Garg, Brendan McClafferty, Devyani Ramgobin, Reshma Golamari, Rahul Jain, Rohit Jain
363 [GO] Future Virology 2020―Oct―28 A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, et al. (+3)
364 [GO] Future Virology 2020―Oct―27 Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
365 [GO] Future Virology 2020―Oct―22 Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng
366 [GO] Future Microbiology 2020―Oct―21 Systemic mycoses: a potential alert for complications in COVID-19 patients Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases
367 [GO] Future Microbiology 2020―Oct―21 Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
368 [GO] Future Cardiology 2020―Oct―20 Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19 Asad J Torabi, Josue Villegas-Galaviz, Maya Guglin, Kyle Frick, Roopa Rao
369 [GO] Future Virology 2020―Oct―14 A comprehensive review about SARS-CoV-2 SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed
370 [GO] Future Virology 2020―Oct―13 Implications of current and future approaches to coronavirus disease 2019 testing Rasheid Smith, Sean M Geary, Aliasger K Salem
371 [GO] Future Cardiology 2020―Oct―09 Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients Lori B Croft, Parasuram Krishnamoorthy, Richard Ro, Malcolm Anastasius, Wenli Zhao, Samantha Buckley, et al. (+5)
372 [GO] Future Virology 2020―Oct―08 The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 Jaclyn Kelly Mann, Thumbi Ndung'u
373 [GO] Future Virology 2020―Oct―08 In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan
374 [GO] Immunotherapy 2020―Sep―22 COVID-19 and the newly rediscovered multidisciplinarity Melissa Bersanelli
375 [GO] Future Microbiology 2020―Sep―21 Potential alteration of COVID-19 by beta-mercaptoethanol Robert E Click
376 [GO] Future Cardiology 2020―Sep―18 Acute type A aortic dissection in a patient with COVID-19 Shiva Tabaghi, Mohammad Ali Akbarzadeh
377 [GO] Pain Management 2020―Sep―18 Reevaluating chronic opioid monitoring during and after the COVID-19 pandemic Prashant N Rao, Rohan Jotwani, Jatin Joshi, Amitabh Gulati, Neel Mehta
378 [GO] Immunotherapy 2020―Sep―16 Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy Melissa Bersanelli, Teresa Zielli, Fabiana Perrone, Chiara Casartelli, Fabiana Pratticò, Elena Rapacchi, et al. (+9)
379 [GO] Immunotherapy 2020―Sep―09 COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, et al. (+2)
380 [GO] Future Oncology 2020―Sep―09 Bioethical considerations for cancer patients care during the COVID-19 pandemic Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad, Michel Scheuer, Roland Tomb
381 [GO] Immunotherapy 2020―Sep―09 Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins José María Díez, Carolina Romero, Júlia Vergara-Alert, Melissa Belló-Perez, Jordi Rodon, José Manuel Honrubia, et al. (+4)
382 [GO] Future Microbiology 2020―Sep―03 SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris
383 [GO] Nanomedicine 2020―Sep―02 No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19 Georgia Wilson Jones, Marco P Monopoli, Luisa Campagnolo, Antonio Pietroiusti, Lang Tran, Bengt Fadeel
384 [GO] Epigenomics 2020―Sep―02 Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2 Antonella Baldassarre, Alessandro Paolini, Stefania Paola Bruno, Cristina Felli, Alberto Eugenio Tozzi, Andrea Masotti
385 [GO] Future Oncology 2020―Aug―28 Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors? Fatih Yildiz, Berna Oksuzoglu
386 [GO] Future Microbiology 2020―Aug―27 Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh
387 [GO] Regenerative Medicine 2020―Aug―26 Digital regenerative medicine and surgery pedagogy for virtual learning in the time of COVID-19 Saranya P Wyles, Fredric B Meyer, Richard Hayden, Isobel Scarisbrick, Andre Terzic
388 [GO] Future Microbiology 2020―Aug―26 Phages in the fight against COVID-19? Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski
389 [GO] Future Virology 2020―Aug―26 Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan
390 [GO] Future Virology 2020―Aug―26 Genetic and pathogenic characterization of SARS-CoV-2: a review Afsane Bahrami, Gordon A Ferns
391 [GO] Future Oncology 2020―Aug―20 Breast cancer surgery after the COVID-19 pandemic Fiona Tsang-Wright, Marios-Konstantinos Tasoulis, Nicola Roche, Fiona MacNeill
392 [GO] Future Virology 2020―Aug―18 A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra
393 [GO] Future Virology 2020―Aug―17 Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid
394 [GO] Future Microbiology 2020―Aug―14 Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, et al. (+3)
395 [GO] Future Virology 2020―Aug―12 Thoughts on detecting tissue distribution of potential COVID-19 receptors Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi
396 [GO] Pain Management 2020―Aug―10 Impact of COVID-19 on chronic pain patients: a pain physician’s perspective Saba Javed, Joey Hung, Billy K Huh
397 [GO] Future Oncology 2020―Aug―10 Recapitulating intracavitary brachytherapy in cervical cancer patients during the COVID-19 pandemic: a viewpoint Divyesh Kumar, Treshita Dey
398 [GO] Colorectal Cancer 2020―Aug―07 Therapeutic challenges in colorectal surgery practice during COVID-19 outbreak: a case series Mahdi Alemrajabi, Mohammad Moradi, Esmail Amiri, Masoud Vahdani
399 [GO] Future Cardiology 2020―Aug―04 Biventricular strain by speckle tracking echocardiography in COVID-19: findings and possible prognostic implications Parasuram Krishnamoorthy, Lori B Croft, Richard Ro, Malcolm Anastasius, Wenli Zhao, Gennaro Giustino, et al. (+5)
400 [GO] Melanoma Management 2020―Jul―31 Pandemic medicine: the management of advanced melanoma during COVID-19 James R Patrinely, Douglas B Johnson
401 [GO] Nanomedicine 2020―Jul―29 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 Noura H Abd Ellah, Sheryhan F Gad, Khalid Muhammad, Gaber E Batiha, Helal F Hetta
402 [GO] Future Virology 2020―Jul―29 In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome Bader Y Alhatlani
403 [GO] Future Virology 2020―Jul―27 COVID-19: studying the global pandemic - foreword Stefano Rusconi, Frederick G Hayden
404 [GO] Future Virology 2020―Jul―27 Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem
405 [GO] Future Oncology 2020―Jul―27 Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic Hagar Elghazawy, Joaira Bakkach, Mohamed S Zaghloul, Atlal Abusanad, Mariam Mohamed Hussein, Mohamed Alorabi, et al. (+6)
406 [GO] Biomarkers in Medicine 2020―Jul―21 The role of hematological parameters in COVID-19 patients in the emergency room Eren Usul, İshak Şan, Burak Bekgöz, Ali Şahin
407 [GO] Immunotherapy 2020―Jul―17 Obesity, COVID-19 and immunotherapy: the complex relationship! Carmine Finelli
408 [GO] Future Oncology 2020―Jul―17 How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer Cengiz Karacin, Irem Bilgetekin, Fatma B Basal, Omur B Oksuzoglu
409 [GO] Future Microbiology 2020―Jul―17 COVID-19: in the absence of vaccination - ‘mask-the-nation’ Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith
410 [GO] Biomarkers in Medicine 2020―Jul―17 The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort Shant Ayanian, Juan Reyes, Lei Lynn, Karolyn Teufel
411 [GO] Immunotherapy 2020―Jul―15 Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients Juan David Cala-García, Juan David Sierra-Bretón, Jorge Eduardo Cavelier-Baiz, Álvaro A Faccini-Martínez, Carlos Eduardo Pérez-Díaz
412 [GO] Future Microbiology 2020―Jul―14 N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester
413 [GO] Future Oncology 2020―Jul―13 The psychological challenges for oncological patients in times of COVID-19 pandemic: telemedicine, a solution? Estelle Caroline Schade, Ronaldo Elkaddoum, Hampig Raphael Kourie
414 [GO] Future Oncology 2020―Jul―13 The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer Veronica Mollica, Alessandro Rizzo, Francesco Massari
415 [GO] Future Cardiology 2020―Jul―10 The impact of COVID-19 on critical cardiac care and what is to come postpandemic Justin Hall
416 [GO] Immunotherapy 2020―Jul―09 How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology Ting Yi Jessica Chang, Janet E Pope
417 [GO] Future Microbiology 2020―Jul―08 The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani
418 [GO] Future Cardiology 2020―Jul―03 Sudden cardiac death in COVID-19 patients, a report of three cases Samira Shirazi, Sanaz Mami, Negar Mohtadi, Abas Ghaysouri, Hamed Tavan, Ali Nazari, et al. (+2)
419 [GO] Future Cardiology 2020―Jul―01 Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure Bhurint Siripanthong, Thomas C Hanff, Michael G Levin, Mahesh K Vidula, Mohammed Y Khanji, Saman Nazarian, Choudhary Anwar A Chahal
420 [GO] Immunotherapy 2020―Jun―29 Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19 Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Alba Ariela Brandes
421 [GO] Future Oncology 2020―Jun―27 Implications of COVID-19 on urological laparoscopic surgery Benjamin Condon, Thomas Whish-Wilson, Niall F Davis, Nathan Lawrentschuk
422 [GO] Future Virology 2020―Jun―26 COVID-19 in homeless populations: unique challenges and opportunities Brian Conway, David Truong, Kelli Wuerth
423 [GO] Future Oncology 2020―Jun―25 Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists Hind Mrabti, Narjiss Berrada, Ghislaine Raiss, Hamza Ettahri, Halima Abahssain, Mouna Bourhafour, et al. (+2)
424 [GO] Future Oncology 2020―Jun―22 A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? Emre Yekedüz, Ayşe Müge Karcıoğlu, Güngör Utkan, Yüksel Ürün
425 [GO] Colorectal Cancer 2020―Jun―20 Official French SARS-CoV-2 guidelines for cancer patients, a triage solution with precision medicine Juan Manuel O’Connor, Federico Esteso, Matías Chacón
426 [GO] Immunotherapy 2020―Jun―17 Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019 Megan Melody, Jared Nelson, Jacquelyn Hastings, Joshua Propst, Michael Smerina, Julio Mendez, Pramod Guru
427 [GO] Future Virology 2020―Jun―12 COVID-19 and coronaviral hepatitis: evidence of collateral damage Mohammad K Parvez
428 [GO] Future Virology 2020―Jun―12 Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin
429 [GO] Future Microbiology 2020―Jun―11 Focus on a 2019-novel coronavirus (SARS-CoV-2) Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang
430 [GO] Pharmacogenomics 2020―Jun―10 Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? Elissar Moujaess, Hampig Raphael Kourie, Joseph Kattan
431 [GO] Pharmacogenomics 2020―Jun―05 Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations Eric M Snyder, Bruce D Johnson
432 [GO] Epigenomics 2020―Jun―04 Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents Sameer Ayaz, Francesco Crea
433 [GO] Biomarkers in Medicine 2020―Jun―03 Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19 Juyi Li, Meng Li, Shasha Zheng, Menglan Li, Minghua Zhang, Minxian Sun, et al. (+4)
434 [GO] Immunotherapy 2020―Jun―03 Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba
435 [GO] Future Oncology 2020―May―29 The future of cancer research after COVID-19 pandemic: recession? Hampig Raphael Kourie, Roland Eid, Fady Haddad, Marwan Ghosn, Dolla Karam Sarkis
436 [GO] Future Virology 2020―May―29 A suspected case of COVID-19 turned into a confirmed case: a case report from Iran Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, et al. (+5)
437 [GO] Future Oncology 2020―May―29 Facing SARS-CoV-2 outbreak in immunotherapy era Fabrizio Citarella, Marco Russano, Francesco Pantano, Emanuela Dell'Aquila, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
438 [GO] Nanomedicine 2020―May―28 Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Vuk Uskoković
439 [GO] Future Oncology 2020―May―27 Hematopoietic stem cell transplantation dilemma during the COVID-19 era Ramy Samaha, Joseph Kattan
440 [GO] Future Oncology 2020―May―27 Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? Priya Hays
441 [GO] Future Oncology 2020―May―26 Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era Antonello Veccia, Stefania Kinspergher, Mariachiara Dipasquale, Orazio Caffo
442 [GO] Future Virology 2020―May―26 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise John Nemunaitis, Laura Stanbery, Neil Senzer
443 [GO] Future Oncology 2020―May―21 Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy Alba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, Federico Cappuzzo, Luigi Cavanna, Giovanni Luca Frassineti, et al. (+8)
444 [GO] Future Virology 2020―May―20 Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections Mona Fani, Ali Teimoori, Shokouh Ghafari
445 [GO] Biomarkers in Medicine 2020―May―19 Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis Nicola Ielapi, Noemi Licastro, Michele Provenzano, Michele Andreucci, Stefano de Franciscis, Raffaele Serra
446 [GO] Future Oncology 2020―May―15 The management of patients with metastatic prostate cancer during the COVID-19 pandemic Tarek Assi, Nathalie Ibrahim, Rita-Maria K Abboud, Clarisse Kattan, Elie Rassy, Elie Nemr, Joseph Kattan
447 [GO] Future Oncology 2020―May―14 Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19 Xuan Rui Sean Ong, Benjamin Condon, Dominic Bagguley, Nathan Lawrentschuk, Arun Azad, Declan Murphy
448 [GO] Future Oncology 2020―May―14 Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what’s old is new again? Ellen O'Connor, Jiasian Teh, Ashish M Kamat, Nathan Lawrentschuk
449 [GO] Future Oncology 2020―May―14 Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care Francesco Massari, Veronica Mollica, Stefania Salvagni, Michele Tognetto, Andrea Ardizzoni
450 [GO] Future Oncology 2020―May―14 Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) Elisa Maria Stroppa, Ilaria Toscani, Chiara Citterio, Elisa Anselmi, Elena Zaffignani, Mauro Codeluppi, Luigi Cavanna
451 [GO] Immunotherapy 2020―May―13 Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens José-María Díez, Carolina Romero, Rodrigo Gajardo
452 [GO] Future Virology 2020―May―12 Prediction and analysis of key protein structures of 2019-nCoV Qihao Li, Wen Peng, Yu Ou
453 [GO] Journal of Comparative Effectiveness Research 2020―May―11 Life after COVID-19: R WE going to help? Sreeram V Ramagopalan, Radek Wasiak
454 [GO] Nanomedicine 2020―May―07 Application of nanomaterials in treatment, anti-infection and detection of coronaviruses Ghazal Nikaeen, Sepideh Abbaszadeh, Saeed Yousefinejad
455 [GO] Future Oncology 2020―May―01 Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
456 [GO] Lung Cancer Management 2020―May―01 Lung cancer management challenges amidst COVID-19 pandemic: hope lives here Abhishek Shankar, Deepak Saini, Ruchir Bhandari, Sachidanand Jee Bharati, Sunil Kumar, Geetika Yadav, et al. (+2)
457 [GO] Immunotherapy 2020―Apr―30 COVID-19: the use of immunotherapy in metastatic lung cancer Alexander P Davis, Michael Boyer, Jenny H Lee, Steven C Kao
458 [GO] Future Virology 2020―Apr―24 The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
459 [GO] Future Oncology 2020―Apr―23 What the oncologist needs to know about COVID-19 infection in cancer patients Elie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, Clarisse Kattan, Tarek Assi, Joseph Kattan
460 [GO] Future Oncology 2020―Apr―23 The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience Clarisse Kattan, Hassan Badreddine, Elie Rassy, Hampig Raphael Kourie, Joseph Kattan
461 [GO] Future Cardiology 2020―Apr―17 Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic Nili Schamroth Pravda, Miri Schamroth Pravda, Ran Kornowski, Katia Orvin
462 [GO] Future Virology 2020―Apr―17 Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
463 [GO] Colorectal Cancer 2020―Apr―16 Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit John L Marshall, Ronit I Yarden, Benjamin A Weinberg
464 [GO] Immunotherapy 2020―Apr―15 Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? Joseph Kattan, Clarisse Kattan, Tarek Assi
465 [GO] Future Oncology 2020―Apr―08 The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic Nizar Bitar, Joseph Kattan, Hampig Raphael Kourie, Deborah Mukherji, Nagi El Saghir
466 [GO] Immunotherapy 2020―Mar―26 Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors Melissa Bersanelli

466 Results       Page 1


Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.038 sec